Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9.
Plasmacytoid urothelial carcinoma is a rare malignant neoplasm in the urinary bladder. A 46-year-old man presented with gross hematuria and increased serum concentrations of both carbohydrate antigen (CA) 19-9 and beta-human chorionic gonadotropin (beta-hCG). The tumor was composed of conventional urothelial carcinoma and plasmacytoid variant, both positive for epithelial markers. In addition, plasmacytoid tumor cells were positive for an accepted marker of plasma cell origin, CD138. CA19-9 was mainly expressed in conventional urothelial carcinoma cells, and beta-hCG was mainly produced by plasmacytoid tumor cells. This is the first report, to our knowledge, indicating beta-hCG can be produced by plasmacytoid bladder cancer cells lacking trophoblastic features.
Shimada
Keiji
K
Department of Pathology, Nara Medical University School of Medicine, Nara, Japan.
Nakamura
Mitsutoshi
M
Ishida
Eiwa
E
Konishi
Noboru
N
D018395:CA-19-9 Antigen / Q000032:analysis / Q000096:biosynthesis*; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000032:analysis / Q000096:biosynthesis*; D003558:Cystoscopy; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis / Q000096:biosynthesis; D008875:Middle Aged; D010950:Plasma Cells / Q000473:pathology; D011509:Proteoglycans / Q000032:analysis / Q000096:biosynthesis; D053668:Syndecan-1; D053667:Syndecans; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000601:surgery
D018395:CA-19-9 Antigen; D018997:Chorionic Gonadotropin, beta Subunit, Human; D008562:Membrane Glycoproteins; D011509:Proteoglycans; C508241:SDC1 protein, human; D053668:Syndecan-1; D053667:Syndecans